From Celgene-Seeded PharmAkea Sells Last Fibrotic Drug Candidate to Galecto:

Ed Hurwitz
Ed Hurwitz

Headshot of Ed Hurwitz, chairman of BioIntervene and managing director at MPM Capital. Photo used courtesy of BioIntervene.